Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 573,234
- Share change
- +382,586
- Total reported value
- $975,780
- Price per share
- $1.70
- Number of holders
- 13
- Value change
- +$645,305
- Number of buys
- 5
- Number of sells
- 7
Report period
Q2 2019
Institutions
13
Top holders
10
ONCY full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
47,984
|
$89,000 | — | 31 Mar 2019 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.04%
|
44,710
|
$82,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
29,520
|
$54,000 | — | 31 Mar 2019 | |
| COMERICA BANK |
13F
|
Company |
0.01%
|
15,526
|
$29,000 | — | 31 Mar 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
15,215
|
$28,000 | — | 31 Mar 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,143
|
$19,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
8,350
|
$15,000 | — | 31 Mar 2019 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
7,985
|
$14,639 | — | 31 Mar 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
5,789
|
$11,000 | — | 31 Mar 2019 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
1,893
|
$4,000 | — | 31 Mar 2019 | |
| NEXT Financial Holdings |
13F
|
Company |
0%
|
1,893
|
$4,000 | — | 31 Mar 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
1,390
|
$3,000 | — | 31 Mar 2019 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1,052
|
$2,000 | — | 31 Mar 2019 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
682
|
$1,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
642
|
$1,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
467
|
$1,000 | — | 31 Mar 2019 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
105
|
$195 | — | 31 Mar 2019 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2019
As of 30 Jun 2019,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
573,234 shares.
The largest 10 holders included
Verition Fund Management LLC, MORGAN STANLEY, SCOTIA CAPITAL INC., COMERICA BANK, ROYAL BANK OF CANADA, Magnus Financial Group LLC, Federation des caisses Desjardins du Quebec, BANK OF MONTREAL /CAN/, DEUTSCHE BANK AG\, and NEXT Financial Group, Inc.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
17
Q2 2019 holders
13
Holder diff
-4
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.